Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
Amy D. Husted, an executive at Kirby Corp, sold a significant number of common shares in May 2026. This transaction occurred against the backdrop of strong corporate performance for Kirby Corporation, which surpassed expectations in its first quarter of 2026 and subsequently raised its growth projections for the full year.
Donald R. Chase, a director at Bluejay Diagnostics, Inc., purchased $25,000 worth of common stock on March 14, 2026. This transaction occurred as the company's stock price traded near its 52-week low. The purchase follows other corporate developments, including a recent private placement and the full exercise of prefunded warrants.
Director Douglas Wurth recently increased his personal stake in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) through a direct purchase of common stock. This transaction occurred against the backdrop of broader company actions, including another private placement raise by board members, the exercise of prefunded warrants, and ongoing financial reporting.
The Chief Executive Officer of Bluejay Diagnostics, Inc., Indranil Dey, recently purchased a significant block of common stock directly from the company. This transaction occurs while the stock trades near its 52-week low, amidst several other reported financial adjustments, including private placements and warrant exercises by board members.
The Chief Accounting Officer of Equitable Holdings, Inc., William James Eckert IV, recently sold a notable quantity of company shares. This activity occurs against the backdrop of the firm reporting strong first-quarter earnings that surpassed market expectations, alongside revenue growth figures that suggest solid operational health for the compan…
Bluejay Diagnostics, Inc.'s director, Fred S Zeidman, recently purchased 12,500 shares of the company's common stock through a private placement. This transaction occurred while the stock traded near its recent 52-week low and is set against a backdrop of other corporate actions, including additional board member investments and warrant exercises.
Jeffrey J. Hurd, Chief Operating Officer of Equitable Holdings (EQH), sold a total value of approximately $609,418 worth of common stock on May 15, 2026. This activity occurred alongside the company's reporting of strong first-quarter financial results for 2026, including earnings and revenue surprises.
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) director Svetlana Dey reported acquiring $25,000 worth of the company's common stock on March 14, 2026. This transaction occurred while the stock was trading near its 52-week low and amidst broader corporate activities including a recent private placement by board members and the full exercise of prefunded wa…
A senior executive at First Merchants Corporation (FRME) recently divested shares, which occurs while the company reports mixed financial results for the first quarter of 2026. Although earnings per share exceeded analyst forecasts, revenue fell short of expectations, painting a picture of strong profitability offset by lower-than-anticipated top-l…
James Carman, President, Houston Region at Howard Hughes Holdings Inc., sold a portion of his company shares in a recent transaction. This selling activity is set against the backdrop of Howard Hughes Holdings' first-quarter 2026 financial results, which featured both a revenue beat and an earnings per share miss.
The Chief Financial Officer of CBRE Group, Inc. recently sold a substantial block of company shares. This insider transaction occurs against a backdrop of strong first-quarter earnings reported by the firm and positive analyst commentary, although the underlying stock has experienced declines over the past week and year-to-date.
The Chief Executive Officer of Maze Therapeutics, Inc. (NASDAQ:MAZE), reported the sale of a portion of his common stock in May 2026. This transaction was executed through a prearranged trading plan and involved shares held via two separate trusts. Despite the recent sales, the company's stock has been highlighted by analysts following positive Pha…
Sanjay Datta, President of Capital & Enterprise at Upstart Holdings, Inc., recently sold a total of 1,817 shares of common stock valued at $53,707. The transaction was reportedly to cover tax withholding related to the vesting of restricted stock units (RSUs). Despite this insider selling activity, the company's recent financial disclosures present…
Joseph M. Manko Jr., a director at Myomo, Inc. (NASDAQ:MYO), recently enhanced his indirect investment in the company through multiple share acquisitions totaling $173,907 over two days in mid-May 2026. This insider activity occurred while MYO shares had appreciated by 7% over the preceding week and were trading at $0.84 with a market capitalizatio…
Director Jeffrey Flug purchased a block of Shake Shack stock, signaling insider buying activity. This transaction occurs while the company's valuation is near its 52-week low, and analysts have issued mixed guidance after reviewing the first quarter of 2026 performance. Some adjustments lowered price targets, while others suggested the market may b…
A notable insider transaction has occurred at Shake Shack Inc. (SHAK), with director Charles J III Chapman acquiring a significant block of Class A common stock. This purchase comes amid varied analyst commentary regarding the company's valuation and future growth, particularly as SHAK trades near its 52-week low.
The report details a recent transaction by Moderna President Stephen Hoge, who sold shares following an earlier acquisition, all conducted under pre-scheduled trading plans. Furthermore, it outlines several material developments for the company, including amendments to its bylaws concerning legal forums and progress in early-stage vaccine research.
Director Daniel Harris Meyer recently acquired a substantial block of Shake Shack Class A Common Stock. This insider transaction occurred while the company's stock price was trading close to its annual low and amid varied reactions from major investment banks regarding the company's recent financial performance.
Ronald Herrmann, an Executive Vice President at Reinsurance Group of America Inc. (NYSE:RGA), sold a total value of approximately $1,474,041 worth of common stock in May 2026. This sale occurred against a backdrop of RGA's impressive first quarter financial results, where the company reported earnings per share (EPS) of $6.97 and revenue of $6.49 b…
The article details a notable sale of Marqeta, Inc. stock by its Chief Administrative Officer. This transaction is presented against the backdrop of the company's recently reported Q1 2026 earnings, where it achieved GAAP profitability and exceeded revenue forecasts. Furthermore, the announcement of a new CTO strengthens the company's technological…
Vital Farms director William B. Cyr recently purchased 6,000 shares of the company's common stock, a transaction totaling $51,120. This buying activity takes place while Vital Farms (NASDAQ:VITL) is experiencing market challenges, including significant analyst downgrades and concerns over industry oversupply.
Miami International Holdings' Executive Vice President and CFO, Lance Emmons, completed a sale of common stock valued at $1.97 million on May 15, 2026. This transaction was executed through a pre-arranged Rule 10b5-1 trading plan. The report details this insider activity alongside the company's recent financial performance, noting that Miami Intern…
The recent activity at Vital Farms, Inc. (NASDAQ:VITL) presents a mix of internal confidence signals and external financial headwinds. Chief Marketing Officer and General Manager of Butter, Kathryn McKeon, purchased company stock on May 14, 2026. This transaction occurred against the backdrop of disappointing Q1 2026 earnings per share (EPS) result…
Vital Farms director Kelly J. Kennedy recently purchased 2,500 shares of the company's common stock on May 14, 2026, totaling $21,000. This acquisition occurred as the stock trades near its 52-week low. The purchase comes against a backdrop of recent negative corporate developments, including a significant earnings miss for Q1 2026 and multiple ana…
Thomas J. Kenny, a director at Aflac Inc., recently sold shares of the company’s common stock on May 15, 2026. This transaction occurred while the stock was trading near its recent high. Despite this insider activity, Aflac provided updates regarding its first-quarter 2026 earnings and ongoing operational developments, including a new facility for …
